Sustained improvement of spinal muscular atrophy mice treated with trichostatin A plus nutrition
about
Spinal muscular atrophyThe contribution of mouse models to understanding the pathogenesis of spinal muscular atrophyHistone deacetylase inhibitors as potential treatment for spinal muscular atrophySpinal muscular atrophy: development and implementation of potential treatmentsSAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophyEarly heart failure in the SMNDelta7 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN deliveryArrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice.Selective Neuromuscular Denervation in Taiwanese Severe SMA Mouse Can Be Reversed by Morpholino Antisense OligonucleotidesTranslational readthrough by the aminoglycoside geneticin (G418) modulates SMN stability in vitro and improves motor function in SMA mice in vivoEffects of 2,4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophyCNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy.PTEN depletion decreases disease severity and modestly prolongs survival in a mouse model of spinal muscular atrophy.Protective effects of butyrate-based compounds on a mouse model for spinal muscular atrophy.Immune dysregulation may contribute to disease pathogenesis in spinal muscular atrophy miceThe effect of diet on the protective action of D156844 observed in spinal muscular atrophy mice.Trans-splicing-mediated improvement in a severe mouse model of spinal muscular atrophy.Effect of diet on the survival and phenotype of a mouse model for spinal muscular atrophySpinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?Mouse survival motor neuron alleles that mimic SMN2 splicing and are inducible rescue embryonic lethality early in development but not lateSpinal muscular atrophy: new and emerging insights from model miceThe Smn-independent beneficial effects of trichostatin A on an intermediate mouse model of spinal muscular atrophy.Spinal muscular atrophy: mechanisms and therapeutic strategies.Motor unit abnormalities in Dystonia musculorum miceAntisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse modelSplicing of the Survival Motor Neuron genes and implications for treatment of SMAAntisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy.Temporal requirement for high SMN expression in SMA miceTherapeutic strategies for the treatment of spinal muscular atrophy.SMN-inducing compounds for the treatment of spinal muscular atrophy.Intramuscular scAAV9-SMN injection mediates widespread gene delivery to the spinal cord and decreases disease severity in SMA mice.Spinal Muscular Atrophy Therapeutics: Where do we Stand?Early functional impairment of sensory-motor connectivity in a mouse model of spinal muscular atrophy.Enhancement of SMN protein levels in a mouse model of spinal muscular atrophy using novel drug-like compoundsIncreased IGF-1 in muscle modulates the phenotype of severe SMA miceSpinal muscular atrophy: from tissue specificity to therapeutic strategiesMotor neuron cell-nonautonomous rescue of spinal muscular atrophy phenotypes in mild and severe transgenic mouse modelsNutritional practices at a glance: spinal muscular atrophy type I nutrition survey findings.Glucose metabolism and pancreatic defects in spinal muscular atrophyIncreasing expression and decreasing degradation of SMN ameliorate the spinal muscular atrophy phenotype in miceVascular perfusion abnormalities in infants with spinal muscular atrophy.
P2860
Q21202863-F8FF8EB7-27E5-4269-A16D-D0286F6AC7E3Q24604444-1B55753C-BF91-47A5-9D40-0D552C0D66DEQ26828876-522A39E0-4E4A-4CD7-A2DF-D6A1A7507A93Q26861377-814E0950-7C1A-4789-A9CD-B8B456EF7FEAQ28271235-8F74C969-E065-485E-A080-D766D46C140BQ28288188-1F0349F4-7C8E-4D02-B2F3-1F073FF22CC4Q28289944-0AF386B3-0076-4A33-87D7-73DF08DDA3E9Q28551647-83C0ACF2-E9DB-4307-A442-D2E4ED674B8EQ30486481-7169D400-90A1-4102-8F6E-0ECAE145BD36Q30492560-43042115-978C-44A7-B0CC-0CEA6C65B551Q30493891-C41A9BA7-004B-44B5-9CB8-18116879CB7EQ30651854-278E1065-0BA1-483B-9C70-EC936EA14D25Q30743508-9EAE2B52-DE3D-4410-91B3-D8BFBD22B559Q33614675-0A5CFF15-AC92-4519-8484-2F237848596BQ33645966-C9172082-FE8B-48E7-A5FF-B4DB1D2C7DAFQ33720730-C5770545-C72F-4C22-A5A3-AB024C8BFA89Q33730194-4F9E7DA1-92AD-483F-8265-D57890B72D67Q33785933-C1C32146-ED76-47B5-B33B-08AD8E5335E1Q33797677-93A65016-39F8-4867-BC1E-F1EDD150AB7FQ33819144-C302ECD2-44ED-4F1B-879B-F7E74D810067Q33830937-E71BB9A1-4060-4A3A-A7D0-59CB6F80C919Q33871311-E00EB938-FBC3-4083-955F-A56E358F543CQ33941149-9A1AB64F-A756-4520-8561-0DEB236850DEQ34030144-1814DBAF-A63F-4EB1-98AF-178324557C7FQ34065993-CE017736-9AEB-4422-A8EC-86E66DB5F45BQ34168139-8917DC3B-5161-4451-A097-41115FABF6EEQ34192528-262C3AD4-D76D-491B-88AA-FE3CFC3D4327Q34296140-22F5EDEE-0CEB-49D8-8051-A9A53CF3615CQ34312156-2B8A9767-929B-4431-B9A1-E9213417262CQ34321271-29869B51-7D8F-4318-B072-6698D8623BAEQ34460251-EAA02E7D-B675-4CB4-9F3B-26C989F70294Q34602175-AEE86F2A-3602-4FA7-B64E-DEB7FC3B985DQ34760255-222C17EE-2A83-49EF-804D-C8CAA86DDD59Q34767012-C6AC0588-D1CF-4FBB-859C-112A4FE81D49Q35029616-5F740998-9E6D-4D80-965B-38291478723EQ35052655-7BECD6A5-9394-4C45-ACD9-9ECD4424CE2DQ35101826-69AE8CD8-F461-4E16-AF58-6581CCA76BC5Q35101838-F89D87C2-A7E8-4DF5-8861-8D0214C39414Q35175035-96A0A971-3FB0-473D-9BEC-54C781153B58Q35647933-E14F103A-1636-4D24-B34E-1A62C977C887
P2860
Sustained improvement of spinal muscular atrophy mice treated with trichostatin A plus nutrition
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Sustained improvement of spina ...... trichostatin A plus nutrition
@ast
Sustained improvement of spina ...... trichostatin A plus nutrition
@en
Sustained improvement of spina ...... trichostatin A plus nutrition
@nl
type
label
Sustained improvement of spina ...... trichostatin A plus nutrition
@ast
Sustained improvement of spina ...... trichostatin A plus nutrition
@en
Sustained improvement of spina ...... trichostatin A plus nutrition
@nl
prefLabel
Sustained improvement of spina ...... trichostatin A plus nutrition
@ast
Sustained improvement of spina ...... trichostatin A plus nutrition
@en
Sustained improvement of spina ...... trichostatin A plus nutrition
@nl
P2093
P2860
P3181
P356
P1433
P1476
Sustained improvement of spina ...... trichostatin A plus nutrition
@en
P2093
Addis A Taye
Barrington G Burnett
Charlotte J Sumner
Dong W Choe
Heather L Narver
Lingling Kong
Marta Bosch-Marcé
Michael A Eckhaus
P2860
P304
P3181
P356
10.1002/ANA.21449
P407
P577
2008-10-01T00:00:00Z